S L Greenspan

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi request reprint Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women
    S L Greenspan
    Department of Medicine, University of Pittsburgh Medical Center, Pennsylvania 15213, USA
    J Clin Endocrinol Metab 85:3537-40. 2000
  2. ncbi request reprint Clinical performance of a highly portable, scanning calcaneal ultrasonometer
    S L Greenspan
    Divisions of Endocrinology and Metabolism, and Geriatric Medicine, University of Pittsburgh Medical Center, 1110 Kaufmann Building, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA
    Osteoporos Int 12:391-8. 2001
  3. pmc The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: a 2-year trial
    G J van Londen
    Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Bone 46:655-9. 2010
  4. ncbi request reprint Evaluation of ability of biochemical markers of bone turnover to predict a response to increased doses of HRT
    H N Rosen
    Charles A Dana Research Institute and the Harvard Thorndike Laboratory of the Beth Israel Deaconess Medical Center, Department of Medicine, Division of Endocrinology, Harvard Medical School, Boston, MA 02215, USA
    Calcif Tissue Int 74:415-23. 2004
  5. pmc The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer
    G J van Londen
    Medicine, University of Pittsburgh, Kaufmann Medical Bldg, Pittsburgh, PA, 15213, USA
    Breast Cancer Res Treat 125:441-6. 2011
  6. ncbi request reprint Classification of osteoporosis and osteopenia in men is dependent on site-specific analysis
    S A Stoch
    Division of Bone and Mineral Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    J Clin Densitom 3:311-7. 2000
  7. pmc Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial
    S L Greenspan
    Department of Medicine, University of Pittsburgh, 3471 Fifth Ave, Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA
    Osteoporos Int 26:1857-64. 2015
  8. ncbi request reprint Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel
    P D Miller
    Department of Medicine, University of Colorado Health Sciences Center and Colorado Center for Bone Research, Denver, CO 80227, USA
    J Clin Densitom 2:323-42. 1999
  9. ncbi request reprint Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists
    S A Stoch
    Division of Bone and Mineral Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    J Clin Endocrinol Metab 86:2787-91. 2001
  10. ncbi request reprint Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis
    S L Greenspan
    University of Pittsburgh Medical Center, Osteoporosis Prevention and Treatment Center, Lilliane S Kaufmann Medical Building, Suite 1110, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA
    J Clin Densitom 4:373-80. 2001

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women
    S L Greenspan
    Department of Medicine, University of Pittsburgh Medical Center, Pennsylvania 15213, USA
    J Clin Endocrinol Metab 85:3537-40. 2000
    ..05). We conclude that early changes in serum NTx and CTx, markers of bone resorption, predict long-term changes in vertebral BMD in elderly women receiving alendronate therapy and provide a useful tool to assess skeletal health...
  2. ncbi request reprint Clinical performance of a highly portable, scanning calcaneal ultrasonometer
    S L Greenspan
    Divisions of Endocrinology and Metabolism, and Geriatric Medicine, University of Pittsburgh Medical Center, 1110 Kaufmann Building, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA
    Osteoporos Int 12:391-8. 2001
    ..We conclude that the QUS-2 calcaneal ultrasonometer exhibits reproducible clinical performance that is similar to BMD of the spine and hip in identifying women with low bone mass and discriminating women with fracture from those without...
  3. pmc The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: a 2-year trial
    G J van Londen
    Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Bone 46:655-9. 2010
    ..Our objectives were to (1) examine the impact of AIs and no-AIs on hip structural geometry (HSA) of chemotherapy-induced postmenopausal women, and (2) determine if oral bisphosphonates could affect these changes...
  4. ncbi request reprint Evaluation of ability of biochemical markers of bone turnover to predict a response to increased doses of HRT
    H N Rosen
    Charles A Dana Research Institute and the Harvard Thorndike Laboratory of the Beth Israel Deaconess Medical Center, Department of Medicine, Division of Endocrinology, Harvard Medical School, Boston, MA 02215, USA
    Calcif Tissue Int 74:415-23. 2004
    ..Measuring of bone density and bone turnover with better precision might be more successful in guiding individual dosing of antiresorptive therapy...
  5. pmc The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer
    G J van Londen
    Medicine, University of Pittsburgh, Kaufmann Medical Bldg, Pittsburgh, PA, 15213, USA
    Breast Cancer Res Treat 125:441-6. 2011
    ..The mechanisms and implications of these changes need to be studied further...
  6. ncbi request reprint Classification of osteoporosis and osteopenia in men is dependent on site-specific analysis
    S A Stoch
    Division of Bone and Mineral Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    J Clin Densitom 3:311-7. 2000
    ..We conclude depending on the number and selection of sites there is considerable variability in the classification and misclassification of osteoporosis and osteopenia in men...
  7. pmc Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial
    S L Greenspan
    Department of Medicine, University of Pittsburgh, 3471 Fifth Ave, Suite 1110, Kaufmann Bldg, Pittsburgh, PA, 15213, USA
    Osteoporos Int 26:1857-64. 2015
    ..Women with the greatest decreases in bone turnover markers at 12 months had the greatest increases in bone density at 24 months...
  8. ncbi request reprint Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel
    P D Miller
    Department of Medicine, University of Colorado Health Sciences Center and Colorado Center for Bone Research, Denver, CO 80227, USA
    J Clin Densitom 2:323-42. 1999
    ..We will describe, in practical terms, how bone markers can be appropriately incorporated into clinical practice today...
  9. ncbi request reprint Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists
    S A Stoch
    Division of Bone and Mineral Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    J Clin Endocrinol Metab 86:2787-91. 2001
    ..In conclusion, men with prostate cancer receiving androgen deprivation therapy have a significant decrease in bone mass and increase in bone turnover, thus placing them at increased risk of fracture...
  10. ncbi request reprint Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis
    S L Greenspan
    University of Pittsburgh Medical Center, Osteoporosis Prevention and Treatment Center, Lilliane S Kaufmann Medical Building, Suite 1110, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA
    J Clin Densitom 4:373-80. 2001
    ..We conclude that IVA is a useful adjunct in the clinical identification of osteoporosis and may prevent mismanagement of osteoporotic patients...
  11. ncbi request reprint Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis
    D C Bauer
    Department of Medicine, University of California San Francisco Coordinating Center, 185 Berry 5700, San Francisco, CA 94107, USA
    J Clin Endocrinol Metab 91:1370-5. 2006
    ..Treatment of osteoporotic women with PTH increases biochemical markers of bone turnover, increases axial bone mineral density (BMD), and reduces fracture risk...
  12. pmc The effect of moderate impact exercise on skeletal integrity in master athletes
    N F Velez
    Department of Medicine, Osteoporosis Center, University of Pittsburgh, 1110 Kaufmann Medical Building, 3471 Fifth Ave, Pittsburgh, PA 15213, USA
    Osteoporos Int 19:1457-64. 2008
    ..Total body BMD was greatest among runners suggesting that moderate impact activities continue to play a role in maintaining skeletal integrity with age...
  13. pmc Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women
    G J van Londen
    Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Bone 43:274-8. 2008
    ..The effect on structural geometry is unknown. Our objective was to determine if oral bisphosphonate therapy could maintain or improve femoral geometry in breast cancer patients with chemotherapy-induced menopause...
  14. pmc Factors associated with diagnosis and treatment of osteoporosis in older adults
    S Nayak
    School of Medicine, Department of Medicine, Division of General Internal Medicine, Section of Decision Sciences and Clinical Systems Modeling, University of Pittsburgh, Pittsburgh, PA, USA
    Osteoporos Int 20:1963-7. 2009
    ..Individuals with several risk factors, including older age, were not more likely to be diagnosed or treated. Measures should be taken to improve osteoporosis identification and treatment in high-risk patients...
  15. ncbi request reprint Vitamin D deficiency is associated with functional decline and falls in frail elderly women despite supplementation
    M P Kotlarczyk
    Department of Medicine, Division of Geriatric Medicine, University of Pittsburgh, 1110 Kaufmann Medical Building, 3471 Fifth Avenue, Pittsburgh, PA, 15213, USA
    Osteoporos Int . 2016
    ..Initial vitamin D deficiency was associated with greater functional decline and increased fall risk despite guideline-recommended supplementation, highlighting the importance of preventing vitamin D deficiency in frail elderly...
  16. ncbi request reprint Uncoupling of bone turnover following hip replacement
    H Whitson
    Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Calcif Tissue Int 71:14-9. 2002
    ..Longer periods of follow-up are needed to assess long-term bone mass changes...